• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于使用LUDI在精细化学品目录中搜索已知三维结构蛋白质的配体。

On the use of LUDI to search the Fine Chemicals Directory for ligands of proteins of known three-dimensional structure.

作者信息

Böhm H J

机构信息

BASF AG, Ludwigshafen, Germany.

出版信息

J Comput Aided Mol Des. 1994 Oct;8(5):623-32. doi: 10.1007/BF00123669.

DOI:10.1007/BF00123669
PMID:7876904
Abstract

It is shown that the computer program LUDI can be used to search large database of three-dimensional structures for putative ligands of proteins with known 3D structure. As an example, a subset of approximately 30,000 small molecules (with less than 40 atoms and 0-2 rotatable bonds) from the Fine Chemicals Directory has been used in the search for possible novel ligands for four different proteins (trypsin, streptavidin, purine nucleoside phosphorylase and HIV protease). For trypsin and streptavidin, known ligands or substructures of known ligands are retrieved as top-scoring hits. In addition, a number of new interesting structures are found in all considered cases. Therefore, the method holds promise to retrieve automatically protein ligands from a 3D database if the 3D structure of the target protein is known.

摘要

结果表明,计算机程序LUDI可用于在三维结构的大型数据库中搜索具有已知三维结构的蛋白质的假定配体。例如,已使用来自精细化学品目录的约30,000个小分子(原子数少于40个且可旋转键数为0 - 2个)的子集来搜索四种不同蛋白质(胰蛋白酶、链霉亲和素、嘌呤核苷磷酸化酶和HIV蛋白酶)的可能新型配体。对于胰蛋白酶和链霉亲和素,已知配体或已知配体的子结构作为得分最高的命中结果被检索到。此外,在所有考虑的案例中都发现了一些新的有趣结构。因此,如果目标蛋白质的三维结构已知,该方法有望从三维数据库中自动检索蛋白质配体。

相似文献

1
On the use of LUDI to search the Fine Chemicals Directory for ligands of proteins of known three-dimensional structure.关于使用LUDI在精细化学品目录中搜索已知三维结构蛋白质的配体。
J Comput Aided Mol Des. 1994 Oct;8(5):623-32. doi: 10.1007/BF00123669.
2
Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.蛋白质配体结合常数的预测:一种用于对从头设计或三维数据库搜索程序所得命中结果进行优先级排序的快速方法。
J Comput Aided Mol Des. 1998 Jul;12(4):309-23. doi: 10.1023/a:1007999920146.
3
QXP: powerful, rapid computer algorithms for structure-based drug design.QXP:用于基于结构的药物设计的强大、快速计算机算法。
J Comput Aided Mol Des. 1997 Jul;11(4):333-44. doi: 10.1023/a:1007907728892.
4
A branch-and-bound method for optimal atom-type assignment in de novo ligand design.
J Comput Aided Mol Des. 1998 Jul;12(4):335-49. doi: 10.1023/a:1007994827087.
5
A novel computational tool for automated structure-based drug design.一种用于基于结构的自动化药物设计的新型计算工具。
J Mol Recognit. 1993 Sep;6(3):131-7. doi: 10.1002/jmr.300060305.
6
Ligand design package (Ludi--MSI) applied to known inhibitors of the HIV-1 protease. Test of performance.配体设计软件包(Ludi--MSI)应用于已知的HIV-1蛋白酶抑制剂。性能测试。
Acta Pol Pharm. 2000 Nov;57 Suppl:25-8.
7
LEA3D: a computer-aided ligand design for structure-based drug design.LEA3D:一种用于基于结构的药物设计的计算机辅助配体设计。
J Med Chem. 2005 Apr 7;48(7):2457-68. doi: 10.1021/jm0492296.
8
Computer-aided design of chiral ligands. Part I. Database search methods to identify chiral ligand types for asymmetric reactions.手性配体的计算机辅助设计。第一部分。用于识别不对称反应手性配体类型的数据库搜索方法。
J Mol Graph Model. 2002 Mar;20(5):399-409. doi: 10.1016/s1093-3263(01)00138-3.
9
Database screening for HIV protease ligands: the influence of binding-site conformation and representation on ligand selectivity.用于筛选HIV蛋白酶配体的数据库:结合位点构象和表示形式对配体选择性的影响。
Proc Int Conf Intell Syst Mol Biol. 1999:242-51.
10
Automated generation of MCSS-derived pharmacophoric DOCK site points for searching multiconformation databases.自动生成源自最小共同结构相似性(MCSS)的药效团对接位点,用于搜索多构象数据库。
Proteins. 2003 May 1;51(2):189-202. doi: 10.1002/prot.10296.

引用本文的文献

1
Theoretical study on the design of allosteric inhibitors of diabetes associated protein PTP1B.糖尿病相关蛋白PTP1B变构抑制剂设计的理论研究
Front Pharmacol. 2024 Aug 22;15:1423029. doi: 10.3389/fphar.2024.1423029. eCollection 2024.
2
In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer.计算机筛选和鉴定一种针对胰腺癌的 MAP4K4 选择性抑制剂及其生物学评估。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2166039. doi: 10.1080/14756366.2023.2166039.
3
10-N-heterocylic aryl-isoxazole-amides (AIMs) have robust anti-tumor activity against breast and brain cancer cell lines and useful fluorescence properties.

本文引用的文献

1
STUDIES ON THE ACTIVE CENTER OF TRYPSIN. THE BINDING OF AMIDINES AND GUANIDINES AS MODELS OF THE SUBSTRATE SIDE CHAIN.胰蛋白酶活性中心的研究。作为底物侧链模型的脒类和胍类的结合
J Biol Chem. 1965 Apr;240:1579-85.
2
Structure-based discovery of inhibitors of thymidylate synthase.基于结构的胸苷酸合成酶抑制剂的发现
Science. 1993 Mar 5;259(5100):1445-50. doi: 10.1126/science.8451640.
3
Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors.强效、可生物利用的非肽环脲作为HIV蛋白酶抑制剂的合理设计。
10-N-杂环芳基异噁唑酰胺(AIMs)具有针对乳腺癌和脑癌细胞系的强大抗肿瘤活性和有用的荧光特性。
Bioorg Med Chem. 2020 Nov 15;28(22):115781. doi: 10.1016/j.bmc.2020.115781. Epub 2020 Sep 24.
4
A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions.利用药理学相互作用鉴定出的一种新型选择性JAK2抑制剂。
Front Pharmacol. 2018 Dec 4;9:1379. doi: 10.3389/fphar.2018.01379. eCollection 2018.
5
Isoxazolo[3,4-d]pyridazinones positively modulate the metabotropic glutamate subtypes 2 and 4.异恶唑并[3,4-d]哒嗪酮正向调节代谢型谷氨酸受体 2 和 4 亚型。
Bioorg Med Chem. 2018 Sep 15;26(17):4797-4803. doi: 10.1016/j.bmc.2018.08.012. Epub 2018 Aug 10.
6
The Nurr1 Ligand,1,1-bis(3'-Indolyl)-1-(-Chlorophenyl)Methane, Modulates Glial Reactivity and Is Neuroprotective in MPTP-Induced Parkinsonism.Nurr1 配体 1,1-双(3'-吲哚基)-1-(-氯苯基)甲烷调节神经胶质细胞的反应性,并在 MPTP 诱导的帕金森病中具有神经保护作用。
J Pharmacol Exp Ther. 2018 Jun;365(3):636-651. doi: 10.1124/jpet.117.246389. Epub 2018 Apr 6.
7
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells.一种靶向核心结合因子Runt结构域以破坏其与白血病细胞中CBFβ结合的工具化合物。
Leuk Lymphoma. 2018 Sep;59(9):2188-2200. doi: 10.1080/10428194.2017.1410882. Epub 2017 Dec 18.
8
Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter.二聚异恶唑基-1,4-二氢吡啶在多药耐药转运蛋白上具有增强的结合能力。
Bioorg Med Chem. 2017 Jun 15;25(12):3223-3234. doi: 10.1016/j.bmc.2017.04.008. Epub 2017 Apr 8.
9
Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors.基于结构筛选鉴定具有垂体瘤治疗潜力的哺乳动物类Ste20激酶4(MST4)抑制剂
Mol Cancer Ther. 2016 Mar;15(3):412-20. doi: 10.1158/1535-7163.MCT-15-0703. Epub 2015 Dec 31.
10
Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors.基于吡咯酮的金属蛋白酶 2 和 3 的抑制剂可能作为构象选择性抑制剂发挥作用。
Chem Biol Drug Des. 2011 Aug;78(2):191-8. doi: 10.1111/j.1747-0285.2011.01148.x. Epub 2011 Jun 20.
Science. 1994 Jan 21;263(5145):380-4. doi: 10.1126/science.8278812.
4
Orientational sampling and rigid-body minimization in molecular docking.分子对接中的取向采样和刚体最小化。
Proteins. 1993 Nov;17(3):266-78. doi: 10.1002/prot.340170305.
5
The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.开发一种简单的经验评分函数,以估计已知三维结构的蛋白质-配体复合物的结合常数。
J Comput Aided Mol Des. 1994 Jun;8(3):243-56. doi: 10.1007/BF00126743.
6
A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.一种用于确定生物学上重要大分子上能量有利结合位点的计算程序。
J Med Chem. 1985 Jul;28(7):849-57. doi: 10.1021/jm00145a002.
7
Quantitative structure-activity relationships and molecular graphics in ligand receptor interactions: amidine inhibition of trypsin.
Mol Pharmacol. 1986 Apr;29(4):436-46.
8
On the rational design of renin inhibitors: X-ray studies of aspartic proteinases complexed with transition-state analogues.关于肾素抑制剂的合理设计:与过渡态类似物复合的天冬氨酸蛋白酶的X射线研究。
Biochemistry. 1987 Sep 8;26(18):5585-90. doi: 10.1021/bi00392a001.
9
Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure.利用形状互补性作为初步筛选方法,来设计针对已知三维结构受体结合位点的配体。
J Med Chem. 1988 Apr;31(4):722-9. doi: 10.1021/jm00399a006.
10
New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure.用于确定已知结构分子上能量有利结合位点的新型氢键势。
J Med Chem. 1989 May;32(5):1083-94. doi: 10.1021/jm00125a025.